Active, Not Recruiting
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
NCT07471815
- Conditions
- Breast Cancer Triple Negative Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China